Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-004460

Chief Medical Officer bought 700 shares at $28.81 ($20,167)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
KENNEY CHRISTOPHER JOHN Chief Medical Officer 2022-01-21 Purchase +700 $28.81 $20,167 700 D
Open-market purchases · 700 sh · avg $28.81 · $20,167
Loading xslF345X03/doc4.xml…